Allred, D. C., Anderson, S. J., Paik, S., Wickerham, D. L., Nagtegaal, I. D., Swain, S. M., . . . Wolmark, N. (2012). Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24. American Society of Clinical Oncology.
Citação norma ChicagoAllred, D. Craig, et al. Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based On NSABP Protocol B-24. American Society of Clinical Oncology, 2012.
ציטוט MLAAllred, D. Craig, et al. Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based On NSABP Protocol B-24. American Society of Clinical Oncology, 2012.